M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Cellectis' Annual Shareholders General Meeting to be Held on June 25, 2026
New York, NY - Cellectis (the "Company") (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 25, 2026...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search